Treatment costs of psoriasis in a tertiary-level clinic.

ABSTRACT:

Background

The costs of psoriasis to a tertiary-level clinic vary considerably depending on the country of study and methods used. Hospitalisation and phototherapy have been significant cost components. This study was performed to estimate the distribution and relative magnitude of the costs of psoriasis to a tertiary-level clinic.

Methods

Based on 233 patients, outpatient and phototherapy visits and the days hospitalised were collected from the treatment provider's records. The visit costs represented true costs, used to charge the final payers. Patients were analysed according to their treatment modalities.

Results

On average, hospitalised patients (3.4%) had 31-fold higher total costs than non-hospitalised patients (p < 0.0001). The costs of hospitalisations formed

SUBMITTER: Mustonen A 

PROVIDER: S-EPMC4141106 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature